Obstruction in Hypertrophic Cardiomyopathy: How Often Does It Occur? Should It Be Treated? If So, How?
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disorder and has been estimated to occur in one of every 500 persons in the general population, amounting to a total of about 600,000 persons in the United States1. Its pathophysiology and optimal management have been the subject of conjecture and debate for more than a century. The issues surrounding left ventricular outflow tract (LVOT) obstruction in HCM have evoked the most discussion.
- Received October 2, 2012.
- Accepted October 3, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited